Changes in cytokine profile with immunotherapy in viral warts using purified protein derivative, mumps measles rubella vaccine, and mycobacterium w vaccine
Background: Immunotherapy for wart employs ability of immune system to recognize certain viral, bacterial, and fungal antigens in previously sensitized individual inducing Type IV delayed-type hypersensitivity reaction (up-regulated Th1 cytokines IL-1, TNF-α, IFN-γ; down-regulated Th2 cytokines IL-1...
Saved in:
Main Authors: | Amrita Sil (Author), Sayantan Dasgupta (Author), Somodyuti Chandra (Author), Adrija Datta (Author), Arini Banerjee (Author), Nilay Kanti Das (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EVALUATION OF THE EFFICACY OF A COMBINATION -MEASLES, MUMPS AND RUBELLA VACCINE IN THE TREATMENT OF PLANTAR WARTS
by: Nagat Sobhy Mohamad, et al.
Published: (2013) -
Mumps, Measles and Rubella Vaccination and Encephalitis
by: J Gordon Millichap
Published: (1989) -
Recalcitrant giant genital wart treated with the combination of measles-mumps-rubella vaccine and human papillomavirus vaccine
by: Tzu-Yu Weng, et al.
Published: (2021) -
Intralesional measles, mumps, and rubella vaccine versus cryotherapy in treatment of warts: A prospective study
by: Harish M Rajegowda, et al.
Published: (2020) -
The efficacy and safety of intralesional immunotherapy with measles, mumps, rubella virus vaccine for the treatment of common warts in adults
by: Pushpinder Singh Chauhan, et al.
Published: (2019)